UK markets closed

Galmed Pharmaceuticals Ltd. (GPH.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.3560+0.0120 (+3.49%)
At close: 08:00AM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 2.24M
Enterprise value -9.36M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.17
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.27

Trading information

Stock price history

Beta (5Y monthly) 0.84
52-week change 3-92.58%
S&P500 52-week change 326.49%
52-week high 34.8600
52-week low 30.2620
50-day moving average 30.3303
200-day moving average 30.4141

Share statistics

Avg vol (3-month) 31.66k
Avg vol (10-day) 36
Shares outstanding 56.01M
Implied shares outstanding 66.29M
Float 85.78M
% held by insiders 13.87%
% held by institutions 13.22%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 315 May 2023

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-28.22%
Return on equity (ttm)-50.63%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -7.46M
Net income avi to common (ttm)-6.91M
Diluted EPS (ttm)-2.3000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)12.64M
Total cash per share (mrq)2.1
Total debt (mrq)41k
Total debt/equity (mrq)0.29%
Current ratio (mrq)4.81
Book value per share (mrq)2.75

Cash flow statement

Operating cash flow (ttm)-6.14M
Levered free cash flow (ttm)-3.63M